RK Capital Management (Colorado)’s BioSpecifics Technologies Corp. BSTC Stock Holding History

RK Capital Management (Colorado)’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-70,801	Closed	-$3.94M	–	60
2016 Q4	$3.94M	Sell	70,801 -77,798	-52%	-$3.74M	0.82%	47
2016 Q3	$6.79M	Sell	148,599 -85,560	-37%	-$3.44M	1.32%	35
2016 Q2	$9.35M	Buy	234,159 +8,641	+4%	+$316K	1.67%	26
2016 Q1	$7.85M	Buy	225,518 +4,900	+2%	+$180K	1.3%	33
2015 Q4	$9.48M	Buy	220,618 +57,812	+36%	+$2.9M	1.66%	29
2015 Q3	$7.09M	Buy	162,806 +45,600	+39%	+$2.46M	1.3%	38
2015 Q2	$6.05M	Buy	+117,206	New	+$5M	1.09%	44

Other funds holding BSTC

JAM

JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

RK Capital Management (Colorado)'s BSTC Position: Q1 2017 in Review

RK Capital Management (Colorado) sold out of BioSpecifics Technologies Corp. (BSTC) in Q1 2017, closing a stake of 70,801 shares — an estimated $3.94M sold.

RK Capital Management (Colorado) first reported a position in BSTC in Q2 2015 and held it in 7 quarters. The position peaked at $9.48M in Q4 2015. 89 funds tracked by Wall St. Rank hold BSTC as of Q1 2017.

RK Capital Management (Colorado) reported no remaining BioSpecifics Technologies Corp. position as of Q1 2017 after selling out during the quarter.
RK Capital Management (Colorado) sold 70,801 BioSpecifics Technologies Corp. shares in Q1 2017, an estimated $3.94M.
RK Capital Management (Colorado) first reported a position in BioSpecifics Technologies Corp. in Q2 2015 and held it in 7 quarters.
RK Capital Management (Colorado)'s BioSpecifics Technologies Corp. position peaked at $9.48M in Q4 2015.
89 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q1 2017.

Based on RK Capital Management (Colorado)'s 13F filing for Q1 2017, filed 11 May 2017.